BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7479343)

  • 1. Changes in amino acid levels in rat plasma, cisternal cerebrospinal fluid, and brain tissue induced by intravenously infused arginine-vasopressin.
    Reichel A; Begley DJ; Ermisch A
    Peptides; 1995; 16(5):965-71. PubMed ID: 7479343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebroventricular infusion but not bolus injection of vasopressin increases the cerebrospinal fluid pressure in awake rabbits.
    Sørensen PS; Gyring JA
    Neurol Res; 1990 Jun; 12(2):83-8. PubMed ID: 1974706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saturable retention of vasopressin by hippocampus vessels in vivo, associated with inhibition of blood-brain transfer of large neutral amino acids.
    Reith J; Ermisch A; Diemer NH; Gjedde A
    J Neurochem; 1987 Nov; 49(5):1471-9. PubMed ID: 2959752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of incremental infusions of arginine vasopressin on adrenocorticotropin and cortisol secretion in man.
    Hensen J; Hader O; Bähr V; Oelkers W
    J Clin Endocrinol Metab; 1988 Apr; 66(4):668-71. PubMed ID: 2831245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebroventricular arginine vasopressin causes intracranial pressure to rise in conscious goats.
    Seckl JR; Lightman SL
    Brain Res; 1987 Oct; 423(1-2):279-85. PubMed ID: 3676810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid pressure during cerebroventricular infusion of angiotensin and vasopressin.
    Barbella YR; Keil LC; Wurpel JN; Severs WB
    Exp Neurol; 1983 Nov; 82(2):325-34. PubMed ID: 6628620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine vasopressin increases renal sodium excretion in the anesthetized rat through V1 receptors.
    Musabayane CT; Forsling ML; Balment RJ
    Ren Fail; 1997 Jan; 19(1):23-32. PubMed ID: 9044449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebroventricular vasopressin reduces CSF absorption rate in the conscious goat.
    Seckl JR; Lightman SL
    Exp Brain Res; 1991; 84(1):173-6. PubMed ID: 1855557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin enhances the clearance of beta-endorphin immunoreactivity from rat cerebrospinal fluid.
    Sweep CG; Boomkamp MD; Barna I; Logtenberg AW; Wiegant VM
    Acta Endocrinol (Copenh); 1990 Feb; 122(2):191-200. PubMed ID: 2138399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin- and phenylephrine-infused conscious rats.
    Magga J; Marttila M; Mäntymaa P; Vuolteenaho O; Ruskoaho H
    Endocrinology; 1994 Jun; 134(6):2505-15. PubMed ID: 8194476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac, neuroendocrine, and behavioral effects of central amygdaloid vasopressinergic and oxytocinergic mechanisms under stress-free conditions in rats.
    Roozendaal B; Schoorlemmer GH; Koolhaas JM; Bohus B
    Brain Res Bull; 1993; 32(6):573-9. PubMed ID: 8221155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do the circulating neurohypophysial hormones affect basal or stress induced prolactin (PRL) release in male rats?
    Jurcovicová J; Dobrakovová M; Oprsalová Z; Jezová D; Makara GB; Kvetnanský R
    Endocr Regul; 1991 Sep; 25(3):159-63. PubMed ID: 1764605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine vasopressin reduces the blood-brain transfer of L-tyrosine and L-valine: further evidence of the effect of the peptide on the L-system transporter at the blood-brain barrier.
    Reichel A; Begley DJ; Ermisch A
    Brain Res; 1996 Mar; 713(1-2):232-9. PubMed ID: 8724995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-cerebrospinal fluid barrier to arginine-vasopressin, desmopressin and desglycinamide arginine-vasopressin in the dog.
    Ang VT; Jenkins JS
    J Endocrinol; 1982 Jun; 93(3):319-25. PubMed ID: 7086325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the blood-brain transfer of L-phenylalanine elicited by arginine vasopressin.
    Ermisch A; Reichel A; Brust P
    Endocr Regul; 1992 Mar; 26(1):11-6. PubMed ID: 1421202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine vasopressin-induced changes in blood flow to the ovine chorion, amnion, and placenta across gestation.
    Hedriana HL; Gilbert WM; Brace RA
    J Soc Gynecol Investig; 1997; 4(4):203-8. PubMed ID: 9292850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of arginine vasopressin on regional adrenal blood flow and plasma cortisol concentration in fetal sheep.
    Carter AM; Challis JR; Svendsen P
    Eur J Obstet Gynecol Reprod Biol; 1995 Oct; 62(2):235-9. PubMed ID: 8582503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous administration of behaviorally effective doses of arginine vasopressin change brain AVP content only in median eminence.
    Deyo SN; Shoemaker WJ; Ettenberg A; Bloom FE; Koob GF
    Neuroendocrinology; 1986; 42(3):260-6. PubMed ID: 3951675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central administration of corticotrophin releasing hormone but not arginine vasopressin stimulates the secretion of luteinizing hormone in rams in the presence and absence of testosterone.
    Tilbrook AJ; Canny BJ; Stewart BJ; Serapiglia MD; Clarke IJ
    J Endocrinol; 1999 Aug; 162(2):301-11. PubMed ID: 10425469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.